Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model–based analysis

N Van de Velde, MC Boily, M Drolet… - Journal of the …, 2012 - academic.oup.com
Background Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. Furthermore, clinical trials examining the efficacy of a …
被引用次数：172 相关文章
[PDF] researchgate.net

[PDF][PDF] Population-level impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis

N Van de Velde, MC Boily, M Drolet, EL Franco… - J Natl Cancer …, 2012 - researchgate.net
Background Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. Furthermore, clinical trials examining the efficacy of a …

[引用][C] Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model―Based Analysis

N VAN DE VELDE, MC BOILY… - Journal of the …, 2012 - pascal-francis.inist.fr
Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human
Papillomavirus Vaccines: A Model―Based Analysis CNRS Inist Pascal-Francis CNRS …

Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis.

N Van de Velde, MC Boily, M Drolet… - Journal of the …, 2012 - europepmc.org
Background Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. Furthermore, clinical trials examining the efficacy of a …

Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis.

N Velde, MC Boily, M Drolet, EL Franco, MH Mayrand… - 2012 - cabidigitallibrary.org
Background: Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. Furthermore, clinical trials examining the efficacy of a …

Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis

N Van de Velde, MC Boily, M Drolet… - Journal of the …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. Furthermore, clinical trials examining the efficacy of a …

Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis.

N Van de Velde, MC Boily, M Drolet… - JNCI: Journal of the …, 2012 - search.ebscohost.com
Background Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. Furthermore, clinical trials examining the efficacy of a …